Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights

Go back to Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights
(NASDAQ: LTRN) Delayed: 1.55 -0.16 (9.36%)
Previous Close $1.71    52 Week High
Open $1.75    52 Week Low
Day High $1.75    P/E N/A 
Day Low $1.55    EPS
Volume 189,726